Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD [chronic obstructive pulmonary disease].

Trial Profile

Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD [chronic obstructive pulmonary disease].

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2010

At a glance

  • Drugs Tiotropium bromide (Primary) ; Ipratropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 01 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top